Genpact Limited (NYSE:G) has received an average recommendation of “Buy” from the twelve ratings firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $34.61.
A number of equities research analysts recently weighed in on G shares. Zacks Investment Research downgraded shares of Genpact from a “buy” rating to a “hold” rating in a research report on Tuesday, January 9th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $36.00 price objective on shares of Genpact in a research report on Tuesday, February 13th. BMO Capital Markets boosted their price objective on shares of Genpact to $35.00 and gave the company a “market perform” rating in a research report on Tuesday, February 13th. Citigroup lowered their price objective on shares of Genpact from $39.00 to $37.50 and set a “buy” rating for the company in a research report on Tuesday, February 13th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Genpact from $38.00 to $37.00 and set a “neutral” rating for the company in a research report on Wednesday, February 14th.
Shares of Genpact (NYSE G) traded up $0.62 during trading on Wednesday, hitting $32.60. 1,040,108 shares of the stock were exchanged, compared to its average volume of 770,022. The firm has a market cap of $6,187.46, a price-to-earnings ratio of 24.33, a PEG ratio of 2.06 and a beta of 0.63. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.71. Genpact has a 1-year low of $23.34 and a 1-year high of $34.79.
Genpact (NYSE:G) last issued its earnings results on Monday, February 12th. The business services provider reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.02. The business had revenue of $734.41 million for the quarter, compared to analyst estimates of $723.55 million. Genpact had a net margin of 9.61% and a return on equity of 22.75%. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.43 EPS. equities analysts expect that Genpact will post 1.55 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 21st. Shareholders of record on Friday, March 9th will be given a $0.075 dividend. This is a boost from Genpact’s previous quarterly dividend of $0.06. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $0.30 annualized dividend and a yield of 0.92%. Genpact’s dividend payout ratio is 22.39%.
In other news, Director James C. Madden sold 4,270 shares of the stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $30.92, for a total value of $132,028.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Arvinder Singh sold 22,690 shares of the stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $33.95, for a total transaction of $770,325.50. The disclosure for this sale can be found here. 1.41% of the stock is currently owned by corporate insiders.
Several institutional investors have recently bought and sold shares of the company. Envestnet Asset Management Inc. boosted its holdings in shares of Genpact by 13.7% in the fourth quarter. Envestnet Asset Management Inc. now owns 35,646 shares of the business services provider’s stock valued at $1,131,000 after acquiring an additional 4,297 shares in the last quarter. J. Goldman & Co LP bought a new position in shares of Genpact in the fourth quarter valued at approximately $4,105,000. We Are One Seven LLC bought a new position in shares of Genpact in the fourth quarter valued at approximately $383,000. Westwood Holdings Group Inc. bought a new position in shares of Genpact in the fourth quarter valued at approximately $24,974,000. Finally, Macquarie Group Ltd. boosted its holdings in shares of Genpact by 1,561.4% in the fourth quarter. Macquarie Group Ltd. now owns 73,100 shares of the business services provider’s stock valued at $2,497,000 after acquiring an additional 68,700 shares in the last quarter. Institutional investors and hedge funds own 90.99% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Analysts Set Genpact Limited (G) PT at $34.61” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another website, it was stolen and republished in violation of US & international trademark & copyright legislation. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/04/09/analysts-set-genpact-limited-g-pt-at-34-61.html.
Genpact Company Profile
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.